Completed Infection & Immunity Genetics & Molecular Biology

Exploring how the germinal center cellular program promotes efficient affinity maturation

In plain English

AI plain-English summary

Every time a vaccine or infection triggers antibody production, B cells inside lymph nodes enter microscopic training camps called germinal centres, where they mutate their antibody genes and compete for survival signals. This fellowship tackles a basic mechanical puzzle inside those cells: how does a B cell rapidly swap out its old antibody receptor for a new, improved version, and how does it ensure that selection rewards only the newest specificity, not the old one it just discarded? The problem matters because the entire quality control system for antibody production depends on this handover happening correctly. If old receptors linger, cells could be selected based on outdated information, producing antibodies that bind poorly to the pathogen. The researcher will build genetic tools to tag and track receptors and MHCII proteins in real time, testing whether antigen presentation is deliberately suppressed during receptor replacement and favoured at other stages. This is fundamental science. It will not produce a vaccine or drug tomorrow. But understanding how germinal centres enforce fidelity in antibody selection could eventually reveal why some vaccines fail to generate long-lasting, high-affinity antibodies, and point toward ways to improve immunisation strategies.

View original technical description
High affinity antibodies develop in germinal centers (GCs) through iterative rounds of somatic hypermutation and selection. Selection involves B cells competing for limiting T cell help; affinity-promoting mutations allow cells to acquire more antigen and present greater amounts of peptide-MHCII. How GC B cells deal with the unique demand of rapidly and repeatedly switching BCR specificity while ensuring selection occurs only on the basis only their newest specificity is not known and will be a major focus of this fellowship. We will generate new genetic tools to allow us to temporally tag and fate-map receptors and MHCII proteins, thereby addressing how and when old molecules are replaced. We will test the hypothesis that antigen-presentation is favored at particular cellular stages, and peptide-MHC complexes degraded at others. The molecular mechanisms controlling this will be examined. GC B cell behavior is determined in large part by an intrinsic cellular program that involves a ti mer component to govern switching between states - we will begin a longer-term quest of understanding how this is regulated by probing changes that occur within individual cells as they transition through the program. This work will help elucidate how quality antibodies are generated during infections and after immunizations.

View the original record at the funder ↗

Researchers

Oliver Bannard (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Factors Determining Clonal Selection in Germinal Centres
Testing the role of B cell receptor signalling in germinal centre responses
Characterisation of B cell gene signatures associated with greater affinity maturation
Defining the nature of plasma cell development in germinal centres.
RNA binding proteins regulate immune responses

Original classification

Sir Henry Dale Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.